US stocks (^DJI, ^IXIC, ^GSPC) capped off Tuesday's session in negative territory, snapping the last two trading days' worth ...

SEATTLE, March 17, 2025 (GLOBE NEWSWIRE) -- Curevo Vaccine (Curevo), a privately-held clinical-stage biotechnology company dedicated to developing varicella zoster virus (VZV) vaccines with improved ...

Recently announced positive data from pivotal randomized, placebo-controlled phase 3 clinical trial of CAN-2409 in ...

Wexford-based biopharmaceutical company Coeptis Inc. announced the formation of GEAR Therapeutics, a majority-owned ...

Transformational drugs rarely emerge from a targeted, application-driven approach. Rather, they arise from deep scientific inquiry over many years, an approach that only robust, early-stage funding ...

IBT is expertly designed and staffed with a collective 150+ years of experience in early-stage research supporting therapeutics and ... Michael Wilhelm, CEO of LNS, stated: “We are excited ...

Cognizant CEO Ravi Kumar S underscored his commitment to the company's future while deemphasizing the legal tussle with Infosys. Notably, Kumar highlighted the firm's transition towards organic ...

Loose is the co-founder and CEO of Progentos Therapeutics, which aims to develop the first potentially restorative therapy for multiple sclerosis. He has a distinguished career in the ...

His work has appeared in The New York Daily News and City & State. Lucid Motors founder and CEO Peter Rawlinson will step down, as the luxury EV company sets its sights on doubling production over ...